Oncoustics (Accelerator)

Company Description: Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, we are not doing image recognition. Instead, we apply AI to raw ultrasound signals from readily available handheld ultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and our approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. (And as our data - >2M pieces of data and growing is part of our IP - we're hard to copy.) Initially, we are targeting liver disease, a $30B global diagnostic market. We have achieved over 93% AUROC for the OnX that detects liver fibrosis - and our 510K is in progress. Several follow-on liver products are in development. We also have clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. We've been in discussion with several pharma companies and are moving forward on a pilot with Roche and have other traction in that space too.